Concepedia

Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype

Catherine Milch, Tim Wyant, Jing Xu, Asit Parikh, Whitney Kent, Irving H. Fox, Joseph R. Berger

Journal of Neuroimmunology · 2013 · 77 citations · 8 references

DOI

Concepts

References

8

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

Dulce Soler, Tobias R. Chapman, Tim Wyant et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 460 citations

, , +17

Immune surveillance in multiple sclerosis patients treated with natalizumab

Olaf Stüve, Christina M. Marra, Keith R. Jerome et al. · Annals of Neurology · 2006 · 437 citations · Full text

, , +15

Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

Olaf Stüve, Christina M. Marra, Amit Bar‐Or et al. · Archives of Neurology · 2006 · 272 citations

, , +17